Fiera Capital (Canada)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $67.3M | Sell |
|
|||||
|
2025
Q2 | $61.7M | Sell |
|
|||||
|
2025
Q1 | $54.7M | Sell |
|
|||||
|
2024
Q4 | $68.1M | Sell |
|
|||||
|
2024
Q3 | $59.5M | Sell |
|
|||||
|
2024
Q2 | $72.7M | Buy |
|
|||||
|
2024
Q1 | $70.6M | Sell |
|
|||||
|
2023
Q4 | $68.1M | Buy |
|
|||||
|
2023
Q3 | $57.5M | Buy |
|
|||||
|
2023
Q2 | $33.8M | Sell |
|
|||||
|
2023
Q1 | $37.4M | Sell |
|
|||||
|
2022
Q4 | $44.5M | Sell |
|
|||||
|
2022
Q3 | $37.5M | Sell |
|
|||||
|
2022
Q2 | $36.9M | Sell |
|
|||||
|
2022
Q1 | $36M | Buy |
|
|||||
|
2021
Q4 | $31M | Sell |
|
|||||
|
2021
Q3 | $38.6M | Sell |
|
|||||
|
2021
Q2 | $39.8M | Sell |
|
|||||
|
2021
Q1 | $40.7M | Buy |
|
|||||
|
2020
Q4 | $39.5M | Buy |
|
|||||
|
2020
Q3 | $27.5M | Buy |
|